139 related articles for article (PubMed ID: 17054434)
1. OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.
Ishiyama T; Kano J; Anami Y; Onuki T; Iijima T; Morisita Y; Yokota J; Noguchi M
Cancer Sci; 2007 Jan; 98(1):50-7. PubMed ID: 17054434
[TBL] [Abstract][Full Text] [Related]
2. Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma.
Hong J; Shiba-Ishii A; Kim Y; Noguchi M; Sakamoto N
Cancer Sci; 2021 Dec; 112(12):5114-5126. PubMed ID: 34628698
[TBL] [Abstract][Full Text] [Related]
3. Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features.
Aviel-Ronen S; Coe BP; Lau SK; da Cunha Santos G; Zhu CQ; Strumpf D; Jurisica I; Lam WL; Tsao MS
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10155-60. PubMed ID: 18632575
[TBL] [Abstract][Full Text] [Related]
4. Global gene expression differentiating pure bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar carcinoma features.
Zhang WC; Zhang ZF; You J; Wang CL
Eur J Cardiothorac Surg; 2013 Apr; 43(4):765-71. PubMed ID: 22864788
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
[TBL] [Abstract][Full Text] [Related]
6. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.
Motoi N; Szoke J; Riely GJ; Seshan VE; Kris MG; Rusch VW; Gerald WL; Travis WD
Am J Surg Pathol; 2008 Jun; 32(6):810-27. PubMed ID: 18391747
[TBL] [Abstract][Full Text] [Related]
7. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B
Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464
[TBL] [Abstract][Full Text] [Related]
8. Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung.
Kobayashi N; Toyooka S; Ichimura K; Soh J; Yamamoto H; Matsuo K; Otani H; Jida M; Kubo T; Tsukuda K; Kiura K; Sano Y; Date H
J Thorac Oncol; 2008 Jul; 3(7):704-10. PubMed ID: 18594314
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development.
Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M
Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198
[TBL] [Abstract][Full Text] [Related]
10. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
[TBL] [Abstract][Full Text] [Related]
12. Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome.
Maki M; JeongMin H; Nakagawa T; Kawai H; Sakamoto N; Sato Y; Noguchi M
Pathol Int; 2022 Oct; 72(10):496-505. PubMed ID: 35920378
[TBL] [Abstract][Full Text] [Related]
13. High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.
Sakashita M; Sakashita S; Murata Y; Shiba-Ishii A; Kim Y; Matsuoka R; Nakano N; Sato Y; Noguchi M
Pathol Int; 2018 Nov; 68(11):596-604. PubMed ID: 30320419
[TBL] [Abstract][Full Text] [Related]
14. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells.
Shih JY; Yang SC; Hong TM; Yuan A; Chen JJ; Yu CJ; Chang YL; Lee YC; Peck K; Wu CW; Yang PC
J Natl Cancer Inst; 2001 Sep; 93(18):1392-400. PubMed ID: 11562390
[TBL] [Abstract][Full Text] [Related]
15. The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status.
Sakao Y; Miyamoto H; Oh S; Takahashi N; Inagaki T; Miyasaka Y; Akaboshi T; Sakuraba M
J Thorac Oncol; 2008 Sep; 3(9):958-62. PubMed ID: 18758296
[TBL] [Abstract][Full Text] [Related]
16. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive adenocarcinomas of the lung.
Dacic S
Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features of lung adenocarcinoma with KRAS mutations.
Kakegawa S; Shimizu K; Sugano M; Miyamae Y; Kaira K; Araki T; Nakano T; Kamiyoshihara M; Kawashima O; Takeyoshi I
Cancer; 2011 Sep; 117(18):4257-66. PubMed ID: 21387273
[TBL] [Abstract][Full Text] [Related]
19. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Travis WD; Garg K; Franklin WA; Wistuba II; Sabloff B; Noguchi M; Kakinuma R; Zakowski M; Ginsberg M; Padera R; Jacobson F; Johnson BE; Hirsch F; Brambilla E; Flieder DB; Geisinger KR; Thunnissen F; Kerr K; Yankelevitz D; Franks TJ; Galvin JR; Henderson DW; Nicholson AG; Hasleton PS; Roggli V; Tsao MS; Cappuzzo F; Vazquez M
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S13-9. PubMed ID: 17409995
[TBL] [Abstract][Full Text] [Related]
20. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization.
Terasaki H; Niki T; Matsuno Y; Yamada T; Maeshima A; Asamura H; Hayabuchi N; Hirohashi S
Am J Surg Pathol; 2003 Jul; 27(7):937-51. PubMed ID: 12826886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]